focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Growth & Income Trust Regulatory News (CYN)

Co-FMs at CQS Natural Resources Growth & Income Trust, discuss their top resource sector investments

Co-FMs at CQS Natural Resources Growth & Income Trust, discuss their top resource sector investments

Share Price Information for CQS Natural Resources Growth & Income Trust (CYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 190.50
Ask: 194.50
Change: -5.00 (-2.56%)
Spread: 4.00 (2.10%)
Open: 190.00
High: 190.00
Low: 190.00
Prev. Close: 195.00
CYN Live PriceLast checked at -
CQS Natural Resources Growth & Income is an Investment Trust

To provide shareholders with capital growth and income predominantly from a portfolio of mining and resource equities and of mining, resource and industrial fixed interest securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Jun 2022 16:29

RNS Number : 0226Q
CQS Natural Resources Grwth&Inc PLC
23 June 2022
 

23 June 2022

 

 

 

CQS Natural Resources Growth and Income plc

(the 'Company')

Legal Entity Identifier: 549300ES8CNIK2CQR054

 

Directorate Change

The Board of CQS Natural Resources Growth and Income plc ("Company") announces that Paul Cahill has been appointed as a Non-Executive Director with effect from today.

Helen Green, Chairman, commented:

"I am delighted to welcome Paul to the Board. He brings a wealth of experience in the natural resources sector, and I am confident that he will make a valuable contribution to the Company."

 

Paul's appointment brings the total number of independent directors to five - Helen Green (Chair), Carole Cable, Paul Cahill, Christopher Casey, and Alun Evans.

 

In accordance with paragraphs 9.6.13 (1) to (6) of the Listing Rules, it is confirmed that there are no additional details to be disclosed in relation to Paul Cahill.

 

About Paul Cahill

In his early career he has worked as an investment banker at Morgan Grenfell and then as a Managing Director at Minorco (Anglo American) where he was responsible for Asia Pacific & Australia, based in Singapore, and worked on several copper and gold joint ventures in Australia, Indonesia, PNG, and the Philippines. He left Anglo American in 2001 to co-lead the establishment, strategic direction and management of Gazelle Corporate Finance, a boutique investment banking business providing corporate finance, M&A and debt restructuring advice to the Boards of FTSE 100 and Fortune 500 companies.

 

Paul returned to Anglo American in 2008 where he became Group Head of Business Development and Head of Strategic Relationships Management. He was a key member of Anglo American's senior leadership team, accountable for the Group's growth agenda and the development and management of the Group's business and relationships in China, India, Japan, Mozambique, Mongolia, Russia, and the DRC. In 2017, Paul became a co-Founder and Managing Director of Bacchus Capital Advisers, an independent investment and merchant banking platform focussed on metals and mining and with particular expertise in public market takeover and defence, complex cross-border M&A, equity and debt financing and corporate restructuring. He remains Chairman of the Bacchus Capital Advisory Board.

 

Paul has over 30 years of experience in the natural resources sector during which time he worked at Anglo American in various roles and in investment banking where he has led the execution of major complex transactions as both a senior adviser and principal. In 2017, Paul co-founded Bacchus Capital Advisers, an independent investment and merchant banking platform focused on metals and mining. He remains Chairman of the Bacchus Capital Advisory Board. Paul also serves as a non-executive director on ASX listed Company Ironbark Zinc Limited and is as a senior adviser to Mitsubushi Corporation.

 

For the Investment Manager

CQS (UK) LLP

Craig Cleland

0207 201 5368

 

For the Company Secretary and UK Administrator

BNP Paribas Securities Services S.C.A. Jersey Branch

Dean Plowman

01534 813967

 

 

Notes to Editors

CQS Natural Resources Growth and Income Trust plc (LSE: CYN) is a closed end investment company, providing shareholders with exposure to a broad portfolio of mining and resource-focused equities, aiming to deliver both steady dividend income and capital growth. The fund is run by experienced fund managers - Ian Francis, Keith Watson, and Rob Crayfourd, and seeks to gain optimal exposure to critical commodities (including base, precious, and battery metals, as well as energy and shipping) across a diverse range of geographies, thereby generating strong returns.

 

The portfolio:

The fund holds a core position in copper which remains a key material in the path to global electrification and the energy transition to net-zero carbon production, therefore displaying encouraging fundamentals for both the short- and long-term. This ties in with the fund's exposure to lithium, nickel and other base metals, which are proving particularly important for advancing battery storage capacity. With the global energy crisis ongoing, we have seen a strong rebound in the oil and gas price supporting our increased weighting. So too, in fiscal uncertainty, as witnessed over the last two years, precious metals like Gold, Silver and Platinum offer protection.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEIFIDEESEEM
Date   Source Headline
16th May 20245:19 pmRNSTransaction in Own Shares
16th May 202411:56 amRNSNet Asset Value(s)
15th May 202412:54 pmRNSNet Asset Value(s)
14th May 20245:14 pmRNSTransaction in Own Shares
14th May 202411:56 amRNSNet Asset Value(s)
13th May 20243:35 pmRNSHolding(s) in Company
13th May 20241:42 pmRNSNet Asset Value(s)
10th May 20244:36 pmRNSTransaction in Own Shares
10th May 202412:43 pmRNSNet Asset Value(s)
10th May 202410:34 amRNSHolding(s) in Company
9th May 20244:56 pmRNSTransaction in Own Shares
9th May 20241:08 pmRNSNet Asset Value(s)
9th May 20248:47 amRNSInvestor Webinar Participation
9th May 20247:00 amRNSAnnual Overview from QuotedData
8th May 20245:06 pmRNSTransaction in Own Shares
8th May 20241:49 pmRNSNet Asset Value(s)
7th May 20244:54 pmRNSTransaction in Own Shares
7th May 202412:56 pmRNSNet Asset Value(s)
3rd May 20245:40 pmRNSTransaction in Own Shares
3rd May 20241:31 pmRNSNet Asset Value(s)
2nd May 20242:16 pmRNSNet Asset Value(s)
1st May 20245:07 pmRNSTransaction in Own Shares
1st May 20245:05 pmRNSNet Asset Value(s)
1st May 202410:10 amRNSTotal Voting Rights
30th Apr 20245:07 pmRNSTransaction in Own Shares
30th Apr 20243:22 pmRNSNet Asset Value(s)
29th Apr 20245:30 pmRNSTransaction in Own Shares
29th Apr 202412:52 pmRNSNet Asset Value(s)
26th Apr 20245:10 pmRNSTransaction in Own Shares
26th Apr 20244:41 pmRNSHolding(s) in Company
26th Apr 20242:19 pmRNSNet Asset Value(s)
26th Apr 20241:25 pmRNSMonthly Fact Sheet as at 31 March 2024
25th Apr 20245:19 pmRNSTransaction in Own Shares
25th Apr 20242:53 pmRNSNet Asset Value(s)
24th Apr 20246:27 pmRNSTransaction in Own Shares
24th Apr 20241:29 pmRNSNet Asset Value(s)
23rd Apr 202412:08 pmRNSNet Asset Value(s)
22nd Apr 20242:01 pmRNSNet Asset Value(s)
19th Apr 202412:56 pmRNSNet Asset Value(s)
18th Apr 20242:19 pmRNSNet Asset Value(s)
17th Apr 202411:32 amRNSNet Asset Value(s)
16th Apr 202412:32 pmRNSNet Asset Value(s)
15th Apr 20241:56 pmRNSNet Asset Value(s)
12th Apr 20241:03 pmRNSNet Asset Value(s)
11th Apr 20243:51 pmRNSNet Asset Value(s)
11th Apr 202412:09 pmRNSHolding(s) in Company
10th Apr 20243:02 pmRNSNet Asset Value(s)
10th Apr 202410:37 amRNSDividend Declaration
9th Apr 20243:01 pmRNSNet Asset Value(s)
9th Apr 20242:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.